T
Telomir Pharmaceuticals Inc
NASDAQ:TELO
Telomir Pharmaceuticals Inc
NASDAQ:TELO
Price:
1.16
USD
-1.69%
Market Closed
Market Cap:
$39.9m
Cash Flow Statement
Cash Flow Statement
Telomir Pharmaceuticals Inc
Telomir Pharmaceuticals Inc
Currency: USD
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
(3)
|
(4)
|
(13)
|
(19)
|
(19)
|
(23)
|
(17)
|
(12)
|
(16)
|
(11)
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
7
|
8
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
1
|
9
|
13
|
13
|
17
|
11
|
8
|
13
|
8
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
2
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Cash from Operating Activities |
(1)
N/A
|
(3)
-173%
|
(4)
-27%
|
(6)
-50%
|
(7)
-13%
|
(6)
+15%
|
(5)
+9%
|
(4)
+21%
|
(3)
+21%
|
(3)
+2%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
1
|
1
|
1
|
7
|
6
|
6
|
7
|
0
|
2
|
7
|
|
| Net Issuance of Debt |
0
|
1
|
3
|
0
|
3
|
0
|
0
|
0
|
0
|
3
|
|
| Other |
(0)
|
1
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
1
N/A
|
3
+172%
|
4
+28%
|
9
+135%
|
8
-7%
|
6
-24%
|
6
-1%
|
0
N/A
|
2
N/A
|
10
+370%
|
|
| Change in Cash | |||||||||||
| Net Change in Cash |
0
N/A
|
(0)
N/A
|
(0)
+95%
|
3
N/A
|
2
-43%
|
1
-55%
|
1
+52%
|
(3)
N/A
|
(1)
+61%
|
6
N/A
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(1)
N/A
|
(3)
-173%
|
(4)
-27%
|
(6)
-50%
|
(7)
-13%
|
(6)
+15%
|
(5)
+9%
|
(4)
+21%
|
(3)
+21%
|
(3)
+2%
|
|
Switch to:
Switch to:
See Also
Discover More
